|
Post by oldfishtowner on Mar 2, 2021 13:15:53 GMT -5
volume at 50 mins of trade. real time, 3,865,053 summary, 7,181,598 Avg. Volume 5,666,83 price bottom, now going up. finance.yahoo.com/quote/MNKD?p=MNKDwww.nasdaq.com/market-activity/stocks/mnkd/real-time3.90-0.11 (-2.7431%) As of 10:23AM EST. Market open. That was hellish. The 20 week MA. the weekly MA's still lining up. I'll take it as the pull back. Look at NK's chart as it was going up. Sharp pull backs along the way. Get the money right. MNKD besides Afrezza has joined a respiratory team. Coming out of COVID respiratory focus doesn't hurt. So Afrezza, and now respiratory meds. The UTHR pipeline starts soon. Back to NK, see the pull backs along the way? See the time line? Maybe we have seen the worst of it. Today the stock closed the Feb 3 gap and bounced off support that I estimated at 3.55 to 3.66 when I looked at the chart last night. Today the stock been mostly churning.
Sure does look like it could be a bottom to me. But I have been fooled before.
|
|
|
Post by sr71 on Mar 2, 2021 13:42:59 GMT -5
Another (good) way to consider events of the past 2 days is realization that share price is still (barely) above it's close exactly one month ago.
Likewise, nothing of great significance has changed regarding MNKD during that month, except securing $200 million (or $300 million if Danbury plant sale/leaseback still happens).
Therefore, in words of a longtime ProBoards poster: "Let's Roll".
MNKD life is finally getting sustainably better (IMHO).
|
|
|
Post by straightly on Mar 2, 2021 14:54:07 GMT -5
Another (good) way to consider events of the past 2 days is realization that share price is still (barely) above it's close exactly one month ago. Likewise, nothing of great significance has changed regarding MNKD during that month, except securing $200 million (or $300 million if Danbury plant sale/leaseback still happens). Therefore, in words of a longtime ProBoards poster: "Let's Roll". MNKD life is finally getting sustainably better (IMHO). Higher low, in other words?
|
|
|
Post by longliner on Mar 2, 2021 15:11:36 GMT -5
What wonders await POWER HOUR?
|
|
|
Post by peppy on Mar 2, 2021 18:51:58 GMT -5
MNKD Nasdaq real time volume, 14,362,652 shares. MNKD Nasdaq summary volume, 23,205,588 shares. Avg. Volume 5,666,835 3.7800. -0.2300 (-5.74%) At close: 4:00PM EST 35% over two days. volume at 50 mins of trade. real time, 3,865,053 summary, 7,181,598 Avg. Volume 5,666,83 finance.yahoo.com/quote/MNKD?p=MNKD www.nasdaq.com/market-activity/stocks/mnkd/real-time
|
|
|
Post by prcgorman2 on Mar 2, 2021 22:57:57 GMT -5
Oh great technical chart lady in the sky, is 23M shares traded in a day the record since FDA approval (or perhaps Sanofi $1B+ worldwide marketing deal)?
Absolutely amazing. Volume we haven’t seen in many years, and only a normal stock’s change in share price. Pinch me. I must be dreaming. Can you spell buoyant?
|
|
|
Post by peppy on Mar 2, 2021 23:34:39 GMT -5
Oh great technical chart lady in the sky, is 23M shares traded in a day the record since FDA approval (or perhaps Sanofi $1B+ worldwide marketing deal)? Absolutely amazing. Volume we haven’t seen in many years, and only a normal stock’s change in share price. Pinch me. I must be dreaming. Can you spell buoyant? 29 million the day before. 52 million over two days. summary volume per monthly. 44 million the month of Sanofi deal.
|
|
|
Post by mnkdfann on Mar 3, 2021 2:27:22 GMT -5
Another (good) way to consider events of the past 2 days is realization that share price is still (barely) above it's close exactly one month ago. Likewise, nothing of great significance has changed regarding MNKD during that month, except securing $200 million (or $300 million if Danbury plant sale/leaseback still happens). Therefore, in words of a longtime ProBoards poster: "Let's Roll". MNKD life is finally getting sustainably better (IMHO). So, you say the share price is back to where it was a month ago, and the company is now saddled with hundreds of millions of dollars of new debt? When you put it like that, I'm even more thankful that the SP has not fallen further.
|
|
|
Post by letitride on Mar 3, 2021 2:39:48 GMT -5
We filled a gap yesterday from 2/2 to 2/3 I love the way that works until it doesn't. Lets Go!
|
|
|
Post by prcgorman2 on Mar 3, 2021 7:29:28 GMT -5
Another (good) way to consider events of the past 2 days is realization that share price is still (barely) above it's close exactly one month ago. Likewise, nothing of great significance has changed regarding MNKD during that month, except securing $200 million (or $300 million if Danbury plant sale/leaseback still happens). Therefore, in words of a longtime ProBoards poster: "Let's Roll". MNKD life is finally getting sustainably better (IMHO). So, you say the share price is back to where it was a month ago, and the company is now saddled with hundreds of millions of dollars of new debt? When you put it like that, I'm even more thankful that the SP has not fallen further. The reason a company is a “pubic” company is because of the need or desire to capitalize their operations. In return for money, they agree to sell equity; a right of ownership in a portion of their company. But there is more obligation than just selling ownership. They’re also agreeing to voting rights (usually), and in some cases a preferred portion to proceeds of liquidation if the company should go bankrupt. But there is still more obligation. At some point of corporate maturity, the shareholders want dividends; a cash distribution of some portion of profit. Corporate finance using other people’s money comes down to two main options; equity or debt. If you study the cost of those two methods of capitalization, the more expensive option is equity because of dividends. In the long run, it is always(?) cheaper to capitalize with debt than it is with equity, because a debt can be paid with no further obligation. You may remember that I’ve been enthusiastic about Mannkind’s improving prospects and that one of the main points of my enthusiasm was that at some point Mannkind would be able to be capitalized on much better, non-toxic, terms than they have for most of the last 7 years. Guess what? We reached that point sooner than I expected, I think. Almost everybody is amazed by the grossly favorable terms of the capitalization. But, are they really grossly favorable? We’ll know more soon. For now, on the face of it, and I think the buoyancy in the stock price underscores this, we should be very happy with this news. The bigger issue now becomes how will Mannkind use this money? I’ve been convinced for a year or so (thanks to Matt, Aged, and a PCP), that for Mannkind to flourish with Afrezza specifically, Mannkind had to address insurance coverage, and prescriber reluctance based on the paucity of convincing safety and efficacy data from clinical trials, and that meant raising a lot of money and therefore on reasonable financial terms because a lot of money on toxic terms is really only a tourniquet designed to stop the bleeding but you may lose a limb or your life. This isn’t a tourniquet. It’s an investment shot in the arm.
|
|
|
Post by peppy on Mar 3, 2021 9:53:56 GMT -5
MNKD Price positive, in a blink, don't blink. average volume for MNKD has increased, to Avg. Volume 6,008,786. Up from 2,500,000 not to long ago.
22 minutes into the trading day, Volume 1,025,509 Avg. Volume 6,008,78
673,837 shares real time.
3.825+0.045 (+1.1905%) As of 9:53AM EST. Market open.
Let's break $4.
I can hope.
|
|
|
Post by peppy on Mar 3, 2021 10:17:09 GMT -5
45 mins of trade. MNKD real time, 1,088,153 MNKD summary,1,948,072 Avg. Volume 6,008,786
Price broke down.
3.67-0.11 (-2.9101%) As of 10:16AM EST. Market open.
Last months low Feb. $3.47
|
|
|
Post by uvula on Mar 3, 2021 10:19:24 GMT -5
The share price was steadily increasing until the moderators moved this thread into a new members only folder. Then everything started to unravel.
Let's move it back and see what happens.
|
|
|
Post by peppy on Mar 3, 2021 10:27:46 GMT -5
The share price was steadily increasing until the moderators moved this thread into a new members only folder. Then everything started to unravel. Let's move it back and see what happens. That would be my preference. I have to be free, I have to be me,,,, There is a song about that. Volume is for everyone.
|
|
|
Post by liane on Mar 3, 2021 10:34:39 GMT -5
Ask, and you shall receive - not that I think it's all related.
|
|